StockData
City Therapeutics, Inc. logo

City Therapeutics, Inc. (CTY) stock

CTYNasdaqPharmaceutical PreparationsFiscal year ends December 31
$18.98+1.97 (+11.58%)

Close on Nov 12, 2026Market cap –P/E –Yield –

Key statistics

Valuation at the latest close; fundamentals over fiscal

Valuation

Market cap
–
P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–
Free cash flow yield
–

Trading

Previous close
$17.01
Open
$16.96
Day's range
$16.65 – $19.43
Volume
216,894
Average volume (20 days)
338,021

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodCTYS&P 500DifferenceCTY per yearS&P 500 per year
1 month-24.2%-2.7%−21.5 pts
3 months-24.2%-1.7%−22.5 pts
Year to date-24.2%+11.9%−36.1 pts
1 year-24.2%+12.0%−36.2 pts
3 years-24.2%+78.2%−102.4 pts-8.8%+21.2%
5 years-24.2%+73.2%−97.5 pts-5.4%+11.6%
10 years-21.3%+309.6%−330.9 pts-2.4%+15.1%

Press releases

Releases City Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K

City Therapeutics stock: common questions

What is City Therapeutics's stock price?

CTY closed at $18.98 on Nov 12, 2026, up 11.58% on the day.

Does City Therapeutics pay a dividend?

No. City Therapeutics has not paid a cash dividend over the last twelve months.

How has CTY stock performed over the past year?

Including dividends, CTY returned -24.2% over the past year, against +12.0% for the S&P 500.

Who are City Therapeutics's competitors?

Companies most similar to City Therapeutics by business, industry and size include LLY, JNJ, ABBV, MRK, AZN.

See a number that looks wrong?